| abstract |
The present invention relates to methods of causing MHC-class II or CD40 mediated immunomodulation, immunosuppression and anti-inflammatory action, i n a subject suffering from or susceptible of suffering from a condition involving inappropriate immune response, which comprises administering to th e subject at least one statin in an amount effective to modulate MHC class II or CD40 expression in the subject. |